![]() |
市场调查报告书
商品编码
1792420
2025 年至 2033 年人工心肺机市场报告(按类型、应用、最终用户和地区)Artificial Heart-Lung Machine Market Report by Type, Application, End User, and Region 2025-2033 |
2024年全球人工心肺机市场规模达3.026亿美元。展望未来, IMARC Group预计到2033年市场规模将达到4.016亿美元,2025-2033年期间的成长率(CAGR)为3.04%。
人工心肺机,又称为心肺旁路 (CPB) 或氧合泵,用于冠状动脉绕道手术、心肺移植以及其他心臟手术。它暂时执行心臟和肺部的功能,使外科医生能够在运动和无血的手术环境中进行手术。这些机器由一个腔室组成,用于接收血液,然后将血液氧合併循环到身体的各个部位。多年来,这些帮浦在严重呼吸衰竭的治疗以及心臟外科手术领域取得了显着进展。
近年来,全球开胸手术、心臟移植和肺部手术的数量显着增加。这主要归因于各种环境和生活方式的变化,这些变化导致心血管疾病和器官衰竭的发生率上升。此外,一些发展中国家的政府正在努力为患者提供更好的医疗设施,这推动了对人工心肺机的需求。此外,市场参与者正在投资研发活动,以更新现有的氧合泵型号。这些活动促成了模组化心肺机的开发,这种机器具有成本效益、安全性和用户友好性。此外,这些机器还为医生提供了灵活性,因为它们便于携带,并且可以使用充电电池供电。製造商也对体外循环帮浦进行了多项改进,以防止血液过度氧合。
The global artificial heart-lung machine market size reached USD 302.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 401.6 Million by 2033, exhibiting a growth rate (CAGR) of 3.04% during 2025-2033.
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.
In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.